Filing Details
- Accession Number:
- 0001078782-16-003581
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-10-06 12:31:45
- Reporting Period:
- 2016-10-05
- Filing Date:
- 2016-10-06
- Accepted Time:
- 2016-10-06 12:31:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
93314 | Volitionrx Ltd | VNRX | In Vitro & In Vivo Diagnostic Substances (2835) | 911949078 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1650670 | Matthew David Kratochvil | 1 Scotts Road #24-05 Shaw Centre Singapore U0 228208 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-10-05 | 10,000 | $5.00 | 10,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- These shares were purchased by the reporting person in connection with an underwritten public offering by the Issuer. The offering closed on October 5, 2016. The reported sale price reflects the price at which the reporting person purchased the shares from the underwriters.